CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. was established on July 31, 2002. It is a Hong Kong-listed subsidiary of CSPC Pharmaceutical Group in Hong Kong-China Pharmaceutical Group Co., Ltd. invested and established in the mainland. Sole proprietorship. The company currently has more than 4,000 employees and total assets of 1.7 billion yuan. It is China's largest supplier of generic drugs and the most professional antibiotic powder injection production base in China.
The products cover hundreds of varieties including antibiotics, digestive system, cardiovascular and cerebrovascular, antipyretic and analgesic, vitamins, etc., including freeze-dried powder for injection, powder for injection, capsules, and tablets , granules and other seven major dosage forms. The main products include penicillin sodium, ampicillin sodium, cefazolin sodium, cefradine, ceftriaxone sodium, cefotaxime sodium, cefoperazone sodium, amoxicillin capsules, amoxicillin dispersible tablets, amoxicillin granules, Guoweikang, etc. . Zhongnuo Pharmaceutical also has strong preparation production capacity, with an annual output of 1.8 billion powder injections, 4.6 billion capsules, and 3.6 billion tablets. Zhongnuo Pharmaceutical is the most important preparation processing and production base in the country.
Zhongnuo Pharmaceutical has always put product quality at the top of corporate development, established a strict three-level quality management system, and fully implemented GMP standards. In addition to complying with domestic and international advanced testing standards such as CP, BP, and USP, the company's products have also established internal corporate standards higher than the above standards to double-check the quality. More than 300 high-quality quality inspection personnel are responsible for quality control of the entire production process, and more than 50 sets of the most advanced testing equipment in the world provide strong quality assurance for product inspection. In addition, Zhongnuo Pharmaceutical has invested hundreds of millions of yuan in GMP transformation. So far, all production workshops have passed GMP certification and obtained 10 "Drug GMP Certificates", including 10 kinds of raw materials and 15 kinds of dosage forms. It is one of the first enterprises in the country to implement GMP certification. While strictly implementing GMP quality standards, the company has launched COS and MCC international quality certification for the international market, accelerating the pace of product internationalization. In addition, the company does not forget to care for the health, safety and environmental protection of its employees, and has passed ISO9001, ISO14001 and OHSAS18000 three system certifications respectively, and established a complete quality assurance system.
Generic drugs require service and quality, but also require continuous innovation and product upgrading to keep up with the latest developments in human health needs. Relying on the strong R&D advantages of CSPC’s postdoctoral workstation, Zhongnuo Pharmaceutical has established a three-level R&D institution specializing in the imitation and development of generic drugs, and has established a high-quality R&D team of more than 200 people in the company and workshops. The team conducts scientific research and tackles key problems, and more than a dozen new products are launched every year. A large number of new products such as Zhongnuo Kelin, Zhongnuo Qiao, Zhongnuo Jialin, Zhongnuo Paishu, and Guowei Kangxin have been launched and become a new force to promote the development of enterprises.
Zhongnuo Pharmaceutical has a sales system for general drugs, new drugs, raw materials, foreign trade, OTC, and health products. It has established more than 60 offices across the country and has a sales team of more than 1,000 people to provide customers with First class professional service. In addition, Zhongnuo Pharmaceutical has established stable economic, technological, and information cooperation relationships with more than 20 countries and regions, including Germany, Japan, Spain, the Netherlands, Switzerland, Denmark, and Italy. With its strong corporate strength, Zhongnuo Pharmaceutical has won wide recognition in the market. CSPC's main trademark was recognized as a well-known trademark in China by the State Administration for Industry and Commerce. CSPC's amoxicillin capsules and ceftriaxone sodium were awarded the title of China's recognized famous brand products. "Shoutang" and "Zhongnuo" were recognized by Hebei Province in December 2006. It was recognized as "Hebei Province Famous Trademark" by the Administration for Industry and Commerce.
As a Hong Kong-funded enterprise in the Mainland, Zhongnuo Pharmaceutical shoulders the unanimous wishes of all Hong Kong shareholders of CSPC and Sinopharm, is based in China, faces the world, and makes a solemn commitment to human health. Faced with the turbulence of the global pharmaceutical economy and the surging tide of China's pharmaceutical development, Zhongnuo Pharmaceutical has determined the "two best" development strategies, namely: to build China's most professional antibiotic powder injection production base and China's most important generic drugs supplier.
Contact person: Dong Qingjie
Region: No. 188, Gongnong Road, Shijiazhuang City, Hebei Province
Postal code: 050051